Fiona Macrae and Sophie Borland
January 14, 2010
More than half the scientists on the swine flu taskforce advising the Government have ties to drug companies.
Eleven of the 20 members of the Scientific Advisory Group for Emergencies (SAGE) have done work for the pharmaceutical industry or are linked to it through their universities.
Many have declared interests in GlaxoSmithKline, the vaccine maker expected to be the biggest beneficiary of the pandemic